Search NLS News

Nordic Biomarker is partnering with private equity company Procuritas. ”Together with our new Swedish majority owner Procuritas, who share our vision for the company to become a leading global supplier of products for reliable coagulation diagnostics, we are now in a better position than ever before to continue to grow and to expand our product […]

BioArctic has announced that the US Patent and Trademark Office (USPTO) has granted a new drug substance patent for the antibody ABBV-0805, invented by BioArctic as a potential treatment of Parkinson’s disease. The patent will take effect on May 24, 2022, and expire in 2041, with the possibility of a patent term extension up until […]

Kaiku Health and Roche are entering a strategic partnership in digital patient monitoring and management (DPMM). Kaiku Health and Roche aim to deploy digital tools to provide real-time symptom management by patients and Health Care Providers (HCPs), improve patient support, and provide personalized cancer care to cancer clinics and patients globally, they state. “Kaiku Health […]

BICO has acquired all the shares in San Diego-based Allegro 3D for an up-front enterprise value of USD 6 million. Additionally, the shareholders can receive USD 5 million in an earnout payment contingent on Allegro 3D’s financial performance in the coming two years. The entire purchase price will be paid in cash. Allegro 3D’s patented […]

Several months after COVID-19, one is still at an increased risk of blood clot and bleeding, shows research from Umeå University. The researchers analyzed all COVID-19 cases in Sweden from the start of the pandemic until May last year. “The results underline the importance of people getting vaccinated against COVID-19 but also of healthcare providers identifying […]

The two companies have announced a collaboration to create a portfolio of novel research programmes to develop transformational medicines. The collaborators will explore opportunities to apply Flagship’s bioplatforms, an ecosystem that currently comprises 41 companies, to scientific challenges in disease areas within cardiometabolic and rare diseases and initiate research programmes based on these. A new […]

AstraZeneca and Daiichi Sankyo’s Enhertu has been approved in the US for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen either in the metastatic setting, or in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within six months of completing […]

Nykode Therapeutics has announced positive interim results from its Phase 2 VB C-02 trial of VB10.16, its wholly-owned therapeutic cancer vaccine, in combination with the PD-L1 inhibitor atezolizumab in patients with HPV16-positive advanced cervical cancer. Interim results from 39 patients with a median follow up of 6 months show an ORR of 21% – including […]

XNK Therapeutics has announced that Ted Fjällman, Partner at Flerie Invest, has joined the company’s board of directors. Flerie Invest led the SEK 132 million financing of XNK earlier this year by placing SEK 100 million and thus gaining approximately 22 percent of the total number of shares and votes in the company, becoming XNK’s […]

The global professional services firm ZS has acquired Danish bioinformatics and systems biology company, Intomics. Founded in Copenhagen, Denmark in 2008, Intomics accelerates and optimizes pharmaceutical drug discovery and development by enabling complex analysis of biomedical data. The addition of renowned scientists to the ZS team will strengthen ZS’s focus on the discovery of new […]